Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 7/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16213964 | 0.98 | MEN1 (0.47) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16214039 | 0.94 | MEN1 (0.43) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16213960 | 0.90 | ADRB2 (0.43) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL10172734 | 0.89 | ADRB2 (0.42) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16214017 | 0.88 | MEN1 (0.38) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16214006 | 0.88 | MEN1 (0.38) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16214000 | 0.83 | MEN1 (0.35) | MEN1KMT2A | |
| SCHEMBL16214906 | 0.82 | MEN1 (0.40) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16213969 | 0.81 | ADRB2 (0.41) | MEN1KMT2AADRB2ADRB1ADRB3 | |
| SCHEMBL16214913 | 0.81 | MEN1 (0.42) | MEN1KMT2AADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8877960-B2 | Fluoroalkanesulfonic acid ammonium salts and method for producing same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-11-04 | — | — | US | disclosed |
| US-20110313190-A1 | Fluoroalkanesulfonic Acid Ammonium Salts and Method for Producing Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313190-A1 | Fluoroalkanesulfonic Acid Ammonium Salts and Method for Producing Same | PFAS, ARSA, NOTUM | MEN1 4487/4885KMT2A 2487/4885ADRB2 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.